Product Information
QC MUCUS RLF COLD-FLU-THRT CPT is a generic product labeled by Chain Drug Marketing Association, priced at $0.1321 per EA under NDC 83324010420. Its NADAC has been published 96 times since Dec 4, 2024.
QC MUCUS RLF COLD-FLU-THRT CPT
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324010420
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/7/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MUCUS RLF COLD-FLU-THRT CPT has been published 96 times since Dec 4, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1321 per EA |
|---|---|
| All-time high | $0.1432 (Aug 12, 2026) |
| All-time low | $0.1267 (Oct 22, 2025) |
| 52-week high | $0.1432 |
| 52-week low | $0.1267 |
| Median price | $0.1322 |
| Average price | $0.1341 |
| Largest weekly change | -6.4% (Sep 23, 2026) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC MUCUS RLF COLD-FLU-THRT CPT?
The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RLF COLD-FLU-THRT CPT, manufactured by Chain Drug Marketing Association, is $0.1321 per EA (NDC 83324010420), effective Sep 30, 2026.
How has the price of QC MUCUS RLF COLD-FLU-THRT CPT changed over time?
Over the history we have for it, the NADAC for QC MUCUS RLF COLD-FLU-THRT CPT has held within roughly two percent of its current level. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC MUCUS RLF COLD-FLU-THRT CPT?
Since Dec 4, 2024, the NADAC for QC MUCUS RLF COLD-FLU-THRT CPT has ranged from a low of $0.1267 (Oct 22, 2025) to a high of $0.1432 (Aug 12, 2026), with a median of $0.1322 per EA.
Are there cheaper alternatives to QC MUCUS RLF COLD-FLU-THRT CPT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC MUCUS RLF COLD-FLU-THRT CPT in a comparable dosage form, but none are currently priced below it.
Who manufactures QC MUCUS RLF COLD-FLU-THRT CPT?
QC MUCUS RLF COLD-FLU-THRT CPT (NDC 83324010420) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.